Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Clinical trial NCT03980483 · COMPLETED
Trial details
- NCT number
- NCT03980483
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-16
- Primary completion
- 2021-09-15
- Enrollment
- 1537
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.